vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v13i4.1087vsp-170Research ArticleОБМЕН ОПЫТОМEXCHANGE OF EXPERIENCEАТОПИЧЕСКИЙ ДЕРМАТИТ: НОВЫЕ ЦЕЛИ ТЕРАПИИATOPIC DERMATITIS: NEW TARGETS OF THERAPYМачарадзеД. С.MacharadzeD. Sh.
Macharadze Dali Shotaevna, PhD, professor of the Department of Allergology and Clinical Immunology
dalim_a@mail.ruРоссийский университет дружбы народов, МоскваРоссияPeople’s Friendship University of Russia, MoscowRussian Federation201402082014134Вопросы современной педиатрии7073Copyright © Мачарадзе Д.С., 20142014Мачарадзе Д.С.Macharadze D.S.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/170детиатопический дерматитрецидивылечениетопические кортикостероидыchildrenatopic dermatitistreatmentrelapsestopical corticosteroids“Bayer”, CJSC.ReferencesThomsen S. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy. 2014; 14: 354–360.Thomsen S. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy. 2014; 14: 354–360.Eichenfield L., Totri C. Optimizing outcomes for paediatric atopic dermatitis. Brit. J. Dermatol. 2014; 170 (Suppl. 1): 31–37.Eichenfield L., Totri C. Optimizing outcomes for paediatric atopic dermatitis. Brit. J. Dermatol. 2014; 170 (Suppl. 1): 31–37.Irvine А., McLean W., Leung D. Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med. 2011; 14: 1315–1327.Irvine А., McLean W., Leung D. Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med. 2011; 14: 1315–1327.Stalder J., Taieb A., Atherton D. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1993; 186: 23–31.Stalder J., Taieb A., Atherton D. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1993; 186: 23–31.Hanifin J., Thurston M., Omoto M., Cherill R., Tofte S., Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp. Dermatol. 2001; 10: 11–18.Hanifin J., Thurston M., Omoto M., Cherill R., Tofte S., Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp. Dermatol. 2001; 10: 11–18.Ring J., Alomar A., Bieber T. Guidelines for treatment of atopic eczema (atopic dermatitis) — part I. J. Eur. Acad. Dermatol. Venerol. 2012; 26: 1045–1060.Ring J., Alomar A., Bieber T. Guidelines for treatment of atopic eczema (atopic dermatitis) — part I. J. Eur. Acad. Dermatol. Venerol. 2012; 26: 1045–1060.Lio P., Lee M., LeBovidge J., Timmons K., Schneider L. Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012. J. Allergy Clin. Immunol. Pract. 2014; 2 (4): 361–369.Lio P., Lee M., LeBovidge J., Timmons K., Schneider L. Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012. J. Allergy Clin. Immunol. Pract. 2014; 2 (4): 361–369.Peserico A., Stadtler G., Sebastian M. et al. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Brit. J. Dermatol. 2008; 158: 801–807.Peserico A., Stadtler G., Sebastian M. et al. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Brit. J. Dermatol. 2008; 158: 801–807.Korting H., Schollmann C. Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index. J. Eur. Acad. Dermatol. Venerol. 2012; 26: 133–140.Korting H., Schollmann C. Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index. J. Eur. Acad. Dermatol. Venerol. 2012; 26: 133–140.El-Batawy M., Bosseila M., Mashaly M., Hafez V. Topical calcineurin inhibitors in atopic dermatitis: A systematic review and metaanalysis. J. Dermatol. Sci. 2009; 54: 76–87.El-Batawy M., Bosseila M., Mashaly M., Hafez V. Topical calcineurin inhibitors in atopic dermatitis: A systematic review and metaanalysis. J. Dermatol. Sci. 2009; 54: 76–87.
The authors declare that there are no conflicts of interest present.